Why the number ‘3’ may make you rethink Covid hysteria

Yesterday I promised to explain why the number three is among the most compelling data points discovered so far in Covid-19 research.

And it’s something that you most likely won’t see in the mainstream media, even though the data is right there in the FDA’s research.

Covid has clearly been THE most heavily researched topic of 2020. Google Scholar shows roughly 90,000 scientific studies and academic papers on SARS-CoV-2 and COVID-19 that were published this year, which is a great testament to how quickly researchers can mobilize.

Many of these studies, however, were limited in nature. They were small-scale, involving only a handful of test subjects. Or they relied upon data from numerous, disparate sources, which introduced a lack of uniformity into the experiment.

But late last week, the FDA published its analysis of the Pfizer/BionTech COVID-19 vaccine trial results, called BNT162b2.

And the results are extremely valuable:

1- The study was very large, involving tens of thousands of people;

2- The participants came from all walks of life and highly diverse genetic compositions;

3- The rules and protocols were completely uniform across the entire experiment.

This is quite rare. Of the nearly 90,000 COVID-19 studies this year, very few meet these criteria.

Perhaps more importantly, there was no funny arithmetic involved, like how the government and media tend to count anyone who sets foot in a hospital or mortuary as Covid-related.

I told you yesterday that the vaccine results are very promising: only 8 people out of 20,033 who received two full doses of the vaccine ended up testing positive for COVID-19.

And perhaps even better, ZERO out of the 805 subjects over the age 75 (who received the vaccine) tested positive for COVID.

So Pfizer has clearly done something extraordinary here.

But as the New England Journal of Medicine wrote late last week, “Important questions of course remain.”

There were numerous adverse reactions to the vaccine, and the Journal rightly wonders whether “unexpected safety issues [will] arise when the number [of vaccinated individuals] grows to millions and possibly billions? Will side effects emerge with longer follow-up? How long will the vaccine remain effective?”

These are among the big questions that remain unanswered.

But the FDA felt that the benefits of Pfizer’s vaccine outweigh its potential risks… so they approved an

Emergency Use Authorization’ for BNT162b2.

And that’s great. Pfizer’s vaccine is now available to anyone who wants one. Imagine if everything in government could move so briskly.

This is what leads me to the number three… because, in addition to the people who received the vaccine, another roughly 20,000 people received a placebo.

How many of them do you think ended up testing positive for Covid during the same evaluation period?

5,000?

500?

Well, out of 20,000 people who did NOT receive the vaccine, 162 of them expressed symptoms of acute respiratory illness and tested positive for COVID-19 during the evaluation period.

And out of those 162 in the placebo group who tested positive for Covid, THREE of them had ‘severe’ Covid. And only one of them was hospitalized.

(The study also clearly defines ‘severe’ Covid by a quantitative measurement of oxygen saturation. So there was no subjectivity involved.)

So from the roughly 20,000 participants who did NOT receive the vaccine, 162 (0.8%) tested positive for COVID-19 during the evaluation period. And THREE (1.9% of the positive tests) had ‘severe’ Covid. [see page 30 of the report]

Remember– this was a BIG test. Tens of thousands of people, from all walks of life, under uniform research conditions. So this is pretty pristine data.

Yet the numbers show that 98% of the people who tested positive for Covid during the evaluation period had a mild case.

It’s astonishing that they still want to shut down the economy given this data.

Now, I’m not dismissing Covid. A lot of people have suffered from it, and a lot of people have died.

But it’s absurd that COVID-19 has become a sacred, hallowed, untouchable topic that outweighs every other priority in our society.

Covid is more important than any other medical condition. It’s more important than freedom. It’s more important than our value system. It’s more important than basic human decency and the ability to engage civilly with one another.

Politicians and public health emperors don’t want a single person to die of Covid. But they don’t give a damn about suicide, drug abuse, alcoholism, domestic violence, and every other disease that’s going untreated right now because of the Covid hysteria.

They’ll happily arrest people who dare to open their businesses. They’ll pepper spray people who, even if sitting by themselves, take off their masks.

They’ll censor and cancel you for expressing a view that doesn’t conform to the fear narrative.

They’ll shame and ridicule you if you have any concerns about the vaccine.

And they want us all afraid and locked up against our will.

Human beings aren’t meant to live like this. Yet now we can see the data for ourselves: 1.9% of people who tested positive for Covid had a severe case.

And if you include people who had asymptomatic Covid and didn’t even realize they were sick, the percentage of severe cases is even lower.

Certainly there will be people who reject this data. But you can’t have it both ways. You can’t dismiss the Covid severity rate while claiming that the vaccine is safe.

Both results come from the same research and the same conditions. So they’re either both true, or neither is true.

Yet all we hear about now is gloom and despair.

Joe Biden talks about the dark winter ahead and waffles about a national lockdown. Bill Gates insists we’ll be locked up until early 2022. And Fauci says even if we take a vaccine we’ll still have to wear masks, social distance, and avoid other people.

But maybe they ought to ‘listen to the scientists’ and have a look at their own data for a change before abusing the Constitution and playing God with people’s lives.

Share this article

About the author

Stay in the loop

Get our new Articles delivered Straight to your inbox, right as we publish them...

141 Shares
Share via
Copy link